# KALLIGA
> **ANDA207081** · Abbreviated New Drug Application (Generic) · Sponsor: AUROBINDO PHARMA · Approved 2017-05-17
## Drug
- **FDA Application Number:** ANDA207081
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** KALLIGA
- **Generic name:** DESOGESTREL AND ETHINYL ESTRADIOL
- **Active ingredients:** DESOGESTREL; ETHINYL ESTRADIOL
- **Dosage form:** TABLET
- **Route:** ORAL-28
- **Marketing status:** Prescription
- **Sponsor:** AUROBINDO PHARMA
- **Manufacturer:** Afaxys Pharma, LLC
- **First approval:** 2017-05-17
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207081)
---
*MORVS · CC0 1.0*